Browsing by Subject "Psoriasis"
Now showing items 1-4 of 4
-
Biologics and Biosimilars as Treatment Options for Psoriasis
(Brac University, 2022-02)Psoriasis is a common chronic skin disease stemming from a systemic inflammatory disorder. It affects more than 7.5 million people in the United States and an estimated 125 million people worldwide. It is an immune-mediated ... -
Detection of skin diseases using deep learning
(2023-09)As a topic of global health importance, skin diseases must be quickly identified and accurately diagnosed to allow for effective treatment. Specifically for the classification of skin diseases, the use of deep learning ... -
A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
(Brac University, 2023-02)FDA has approved about 12 biologics for treating psoriasis. Among them, TNF-α inhibitors have a history of causing alopecia while used for treatment. In our study, we tried to find out the relation between alopecia and the ... -
TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study
(Brac University, 2023-02)The objective of this study was to investigate the association between TNF-alpha inhibitors and alopecia cases in psoriasis patients reported in the Food and Drug Administration Adverse Event Reporting System (FAERS) ...
